MedTrace Logo

A Bundled Rapid HIV/HCV Testing Intervention to Increase Receipt of Test Results

NCT02355080 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 134

Last updated 2018-02-23

No results posted yet for this study

Summary

This is a randomized controlled clinical trial in which adults receiving drug abuse treatment will be recruited to participate in a HIV and hepatitis C (HCV) testing study. The purpose of this study is to test the efficacy of two HIV/HCV testing strategies on increasing receipt of test results: (1) on-site bundled rapid HIV/HCV testing (i.e., joint offer of HIV and HCV at the point of encounter), and (2) standard of care for HIV and HCV testing.

Conditions

  • Substance-related Disorders

Interventions

BEHAVIORAL

On-site bundled rapid HIV/HCV testing

Participants will be offered bundled on-site rapid HIV and HCV testing with post-test counseling that addresses both sexual and drug use risk reduction, and linkage to care.

BEHAVIORAL

Standard of care (SOC)

Participants will receive the SOC for HIV and HCV testing at the study sites.

Sponsors & Collaborators

  • New York University

    collaborator OTHER

  • Beth Israel Medical Center

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Jemima A. Frimpong, PhD, MPH · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02355080 on ClinicalTrials.gov